Vildagliptin Tablets 50mg (Equa® / エクア錠50mg)

JPY ¥5,800

Japanese Selective DPP-4 Inhibitor (Vildagliptin 50mg). Oral tablet for the treatment of type 2 diabetes mellitus, administered twice daily. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Novartis Pharma K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥5,336
10 - 19 12% JPY ¥5,104
20 + 18% JPY ¥4,756
SKU: EQU-50-TAB Category:

Description

Product Overview / 商品概要

Equa Tablets 50mg (エクア錠50mg)
Generic: Vildagliptin / ビルダグリプチン
Therapeutic Category: Selective DPP-4 Inhibitor [Type 2 Diabetes Mellitus Treatment] / 選択的DPP-4阻害薬[2型糖尿病治療薬]
Manufactured by: Novartis Pharma K.K. / ノバルティスファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Vildagliptin 50mg per tablet / 1錠中ビルダグリプチン50mg
Additives: Cellulose, Lactose, Sodium starch glycolate, Magnesium stearate / セルロース、乳糖、デンプングリコール酸ナトリウム、ステアリン酸マグネシウム
Appearance: White to slightly yellowish-white uncoated tablet with a score line on one side. Diameter: 8.0mm, Thickness: 3.6mm, Weight: 0.20g. Identification code: NVR FB
外観: 白色~微黄白色の片面割線入りの素錠。直径:8.0mm、厚さ:3.6mm、質量:0.20g。識別コード:NVR FB

Indications / 効能効果

EN: Type 2 diabetes mellitus
JA: 2型糖尿病

Dosage and Administration / 用法用量

EN: The usual adult dose is 50mg of vildagliptin administered orally twice daily in the morning and evening. Depending on the patient’s condition, 50mg may be administered once daily in the morning.
JA: 通常、成人には、ビルダグリプチンとして50mgを1日2回朝、夕に経口投与する。なお、患者の状態に応じて50mgを1日1回朝に投与することができる。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; patients with diabetic ketoacidosis, diabetic coma, or type 1 diabetes mellitus; patients with severe hepatic impairment; patients with serious infections, perioperative conditions, or severe trauma
JA: 本剤の成分に対し過敏症の既往歴のある患者、糖尿病性ケトアシドーシス・糖尿病性昏睡・1型糖尿病の患者、重度の肝機能障害のある患者、重症感染症・手術前後・重篤な外傷のある患者

Regulatory Information / 規制情報

Approval No.: 22200AMX00233000
Sales Started: April 2010 / 2010年4月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Vildagliptin Tablets 50mg (Equa® / エクア錠50mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Vildagliptin Tablets 50mg (Equa®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.